BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36143915)

  • 1. Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy.
    Gales L; Forsea L; Mitrea D; Stefanica I; Stanculescu I; Mitrica R; Georgescu M; Trifanescu O; Anghel R; Serbanescu L
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
    Benjamin DJ; Haslam A; Prasad V
    Cancer Med; 2024 Mar; 13(5):e7049. PubMed ID: 38491813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in Vivo.
    Wang ZS; Huang HR; Zhang LY; Kim S; He Y; Li DL; Farischon C; Zhang K; Zheng X; Du ZY; Goodin S
    Biol Pharm Bull; 2017; 40(8):1247-1254. PubMed ID: 28769006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential anti-cancer drugs commonly used for other indications.
    Hanusova V; Skalova L; Kralova V; Matouskova P
    Curr Cancer Drug Targets; 2015; 15(1):35-52. PubMed ID: 25544649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and cancer: licence to heal?
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Investig Drugs; 2010 Aug; 19(8):913-7. PubMed ID: 20557275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer.
    Amin S; Boffetta P; Lucas AL
    Gut Liver; 2016 Sep; 10(5):665-71. PubMed ID: 27563018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel prospects of statins as therapeutic agents in cancer.
    Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
    Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
    Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H
    Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug administration in patients with diabetes mellitus. Safety considerations.
    Gilbert RE; Cooper ME; Krum H
    Drug Saf; 1998 Jun; 18(6):441-55. PubMed ID: 9638389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
    Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
    Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
    Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
    Haukka J; Niskanen L; Auvinen A
    Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database.
    MacDonald MR; Eurich DT; Majumdar SR; Lewsey JD; Bhagra S; Jhund PS; Petrie MC; McMurray JJ; Petrie JR; McAlister FA
    Diabetes Care; 2010 Jun; 33(6):1213-8. PubMed ID: 20299488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies.
    Bens A; Langballe R; Bernstein JL; Cronin-Fenton D; Friis S; Mellemkjaer L
    Acta Oncol; 2019 Nov; 58(11):1581-1593. PubMed ID: 31393200
    [No Abstract]   [Full Text] [Related]  

  • 17. What every dentist should know about metformin, diabetes, and cancer.
    Frykenberg MR; Schneider A; Bashirelahi N
    Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.